Khubchandani, in his most recent role, has served as Co-CEO and Whole-time Director of Jubilant Ingrevia. Over his 20-year career at Jubilant Ingrevia, Khubchandani was a strategic business leader, developed high-performing teams, and oversaw solutions and offerings for pharmaceutical, agrochemical, and industrial clients.
Sekhmet Pharmaventures is the India arm of Gamot API Pte. Ltd., a Singapore-based platform launched by PAG along with Indian private equity firms CX Partners and Samara Capital to buy stakes in fast-growing pharma companies. The platform acquired control of Chennai-based Anjan Drug Pvt. Ltd. in October 2020 and the Hyderabad-based Optimus Drugs group of companies in September 2022. Gamot API is majority owned by PAG, which has invested over $1.5 billion in India across its private equity and debt businesses.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.